Efficacy and safety of Chinese medicine compound for the convalescent COVID-19 patients: Protocol of a multi-centered, randomized, double-blinded, placebo-controlled clinical trial
This study aimed to verify whether SLKF granules can significantly improve clinical symptoms, including fatigue, loss of appetite, cough, phlegm, and insomnia, in patients with convalescent COVID-19. For a comprehensive investigation, additional clinical trials with larger sample sizes and longer intervention periods are required.Clinical Trial Registration Center NCT1900024524, Registered on 26 January 2024.
Authors
- Le Xie (ORCID: https://orcid.org/0000-0002-9931-328X)
- Wookyeom Yang (ORCID: https://orcid.org/0000-0002-3970-7973)
- Rui Fang (ORCID: https://orcid.org/0000-0001-6075-9201)
- Yue Zhou (ORCID: https://orcid.org/0000-0002-8624-8730)
- Qing Chen (ORCID: https://orcid.org/0000-0003-4108-7977)
- Yunhua Luo (ORCID: https://orcid.org/0000-0003-0271-1319)
- Shasha Zhou (ORCID: https://orcid.org/0000-0003-0396-9450)
- Jinwen Ge (ORCID: https://orcid.org/0000-0003-4695-0012)
- Jie Tian (ORCID: https://orcid.org/0000-0003-0498-0432)
- Yanmei Peng (ORCID: https://orcid.org/0000-0002-7801-8994)
- Danhong Liu
- Dahua Wu
- Lei Zhao (ORCID: https://orcid.org/0000-0003-0536-8675)
Institutions
- Hunan University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
- Hunan Academy of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1016/j.conctc.2025.101557
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00